Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 May 12, 2026 FORM 4
144 May 8, 2026
4 May 8, 2026 FORM 4
4 May 8, 2026 FORM 4
4 May 8, 2026 FORM 4
4 May 8, 2026 FORM 4
4 May 8, 2026 FORM 4
3 May 8, 2026 FORM 3
144 May 7, 2026
144 May 7, 2026
SCHEDULE 13G/A May 7, 2026
144 May 7, 2026
144 May 7, 2026
SCHEDULE 13G Apr 29, 2026
ARS Apr 29, 2026 ARS
DEF 14A Apr 29, 2026 AXGN DEFINITIVE PROXY STATEMENT
10-Q Apr 28, 2026 FORM 10-Q
8-K Apr 28, 2026 FORM 8-K
← Newer Page 2 of 54 · 1328 filings Older →